Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Epizyme, Inc. (1)

St. Jude Children's Research Hospital (1)

Collaborator

National Cancer Institute (NCI) (1)

National Institute of General Medical Sciences (NIGMS) (1)

Intervention

itraconazole (1)

rifampin (1)

tazemetostat (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

All Malignancies

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

All Malignancies, Advanced Malignancies, Hematologic Malignancy Trial in Spain, United States (Tazemetostat, Itraconazole,

Active, not recruiting

All Malignancies
+11 more

Tazemetostat
+2 more

Encinitas, California
+9 more

May 20, 2022

Pharmacogenetic Determinants Of Treatment Response In Children

Recruiting

All Malignancies
Children Being Treated for Catastrophic Illness

Memphis, Tennessee

St. Jude Children's Research Hospital

Mar 29, 2022